You are here

Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug

Forbes

Wed, 06/19/19 - 09:55 am

Tags:

Bluebird Bio, gene therapy, drug pricing, Zynteglo, beta thalassemia

Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks

Biopharma Dive

Tue, 06/18/19 - 11:57 am

Tags:

Bluebird Bio, gene therapy, drug manufacturing, Zynteglo

bluebird offers installment payments for Zynteglo gene therapy

Pharmaforum

Mon, 06/17/19 - 12:25 pm

Tags:

Bluebird Bio, outcome-based pricing, drug pricing, gene therapy, Zynteglo, beta thalassemia

Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous?

Motley Fool

Sat, 06/15/19 - 05:49 pm

Tags:

Bluebird Bio, Zynteglo, drug pricing, beta thalassemia

Bluebird sets $1.8M price tag for blood-disease gene therapy

Biopharma Dive

Fri, 06/14/19 - 12:08 pm

Tags:

drug pricing, Bluebird Bio, Zynteglo, Europe, beta thalassemia

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts

Yahoo/Benzinga

Sun, 06/9/19 - 01:36 pm

Patients, payers await pricing plans for bluebird's first approved gene therapy

BioCentury

Tue, 06/4/19 - 11:04 am

Tags:

Bluebird Bio, gene therapy, Zynteglo, drug pricing, beta thalassemia

Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval

Xconomy

Mon, 06/3/19 - 07:50 pm

Tags:

Bluebird Bio, gene therapy, Europe, Zynteglo, EMA, beta thalassemia

Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big

Motley Fool

Sun, 05/19/19 - 04:05 pm

Tags:

Alexion, Ultomiris, AbbVie, Upadacitinib, risankizumab, Aimmune Therapeutics, AR-101, Bluebird Bio, LentiGlobin

Bluebird's not looking to break speed records with its first gene therapy launch

Fierce Pharma

Fri, 05/10/19 - 12:48 pm

Tags:

Bluebird Bio, gene therapy, beta thalassemia, Zynteglo, drug launches

bluebird to rollout Zynteglo starting in Germany next half

BioCentury

Thu, 05/9/19 - 11:09 pm

Tags:

Bluebird Bio, beta thalassemia, Germany, Zynteglo

bluebird bio Flies Forward

Motley Fool

Wed, 05/8/19 - 10:12 am

Tags:

Bluebird Bio, earnings

Celgene reports 'durable' responses to multiple myeloma CAR-T in early trial despite relapses

Fierce Biotech

Fri, 05/3/19 - 10:45 am

Tags:

Celgene, Bluebird Bio, bb2121, cell therapy, CAR-T, Multiple Myeloma

Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit

Fierce Pharma

Tue, 04/23/19 - 11:05 pm

Tags:

Sanofi, Bluebird Bio, Kendall Square, Boston

Here's Why Shares of bluebird bio Slumped Today

Motley Fool

Wed, 04/17/19 - 10:36 pm

Tags:

2 Blockbuster Gene Therapy Programs to Watch in 2019

Motley Fool

Sun, 03/31/19 - 03:42 pm

Tags:

gene therapy, Zolgensma, Novartis, Bluebird Bio, LentiGlobin

First gene therapy to treat rare blood disease nears European approval

Stat

Fri, 03/29/19 - 10:05 am

Tags:

Bluebird Bio, Europe, LentiGlobin, gene therapy, beta-thalassemia

Bluebird opens manufacturing facility as it moves gene therapies forward

Fierce Pharma

Tue, 03/26/19 - 11:39 am

Tags:

Bluebird Bio, gene therapy, cell therapy, drug manufacturing

bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire

BioSpace

Fri, 03/22/19 - 10:06 pm

Tags:

Bluebird Bio, gene therapy, drug manufacturing, bb2121, bb21217, LentiGlobin

Here's Why bluebird bio Gained 16.3% in February

Motley Fool

Mon, 03/11/19 - 09:50 am

Tags:

Pages

last 30 twitter posts